OpenVSafe by OpenVAERS
Search V-safe

85C-30342-68561

4 vaccinations 7 coded responses 48 check-ins 7 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
481 / MI
Registered
2021-01-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-08
    Dose 1 — Moderna
  2. 2021-01-10
    Registered in v-safe
  3. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  4. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-15
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-01-29
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-02-05
    Dose 2 — Moderna
  9. 2021-02-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthenia, Dizziness — Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Weakness, dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  11. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  12. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache
    Adult check-in
  13. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-14
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-19
    Survey response — day 14, dose 2
    MedDRA: Rash, Rash erythematous, Rash maculo-papular, Rash pruritic — Feeling: Fair
    Free text: Itchy and red maculopapular rash under both arms.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-26
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-07
    Survey response — 3 months, dose 2
    MedDRA: Condition aggravated, Mastitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Recurrent breast infections
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-05-07
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-08-06
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-10-23
    Dose 3 — Moderna
  25. 2021-10-23
    Survey response — day 0, dose 3
    MedDRA: Dizziness — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Dizziness
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  27. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Adult check-in
  28. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches, Nausea
    Adult check-in
  29. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  30. 2021-10-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-10-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-10-30
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-11-06
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-13
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-20
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-27
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-04
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-01-22
    Survey response — 3 months, dose 3
    MedDRA: Ageusia, Anosmia, Confusional state, Dyspnoea, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: These are long-Covid symptoms I am having: loss of taste and smell, shortness of breath, confusion.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-04-02
    Dose 4 — Moderna
  40. 2022-04-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  41. 2022-04-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  42. 2022-04-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  43. 2022-04-06
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  44. 2022-04-07
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  45. 2022-04-08
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  46. 2022-04-09
    Health check-in — day 7, dose 4
    Feeling: Good · Chills, Headache · Be unable to work or attend school
    Adult check-in
  47. 2022-04-16
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-04-23
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  49. 2022-04-30
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  50. 2022-05-05
  51. 2022-05-05
  52. 2022-05-05
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  53. 2022-05-08
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-05-14
    Survey response — day 42, dose 4
    MedDRA: Menstrual clots, Menstruation irregular — Feeling: Good
    Free text: Irregular menstrual periods. Now develop small clots during period.
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-07-02
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-10-01
    Survey response — 6 months, dose 4
    MedDRA: Abortion spontaneous, COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: COVID-19, miscarriage at 16 weeks gestation
    MedDRA releases: 2024-11 · check-in free text available
  57. 2022-10-01
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  58. 2022-10-06
  59. 2022-10-07
    Call successful
    Does not wish to fill out VAERS report
  60. 2023-04-02
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-08Moderna
22021-02-05Moderna
32021-10-23Moderna No
42022-04-02Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2021-05-07 Successful
2022-05-05
 Reported to VAERS voluntarily prior to GDIT contact
2022-10-01 Successful
2022-10-07
 Does not wish to fill out VAERS report

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-06

Systemic reaction (other): Weakness, dizziness

Release 4 — day 14, dose 2

2021-02-19

Symptoms: Itchy and red maculopapular rash under both arms.

Release 8 — 3 months, dose 2

2021-05-07

Symptoms: Recurrent breast infections

Release 10 — day 0, dose 3

2021-10-23

Systemic reaction (other): Dizziness

Release 11 — 3 months, dose 3

2022-01-22

Symptoms: These are long-Covid symptoms I am having: loss of taste and smell, shortness of breath, confusion.

Release 11 — day 42, dose 4

2022-05-14

Symptoms: Irregular menstrual periods. Now develop small clots during period.

Release 12 — 6 months, dose 4

2022-10-01

Symptoms: COVID-19, miscarriage at 16 weeks gestation

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDAgeusia · · ✓
SDAnosmia · · ✓
SDCondition aggravated ✓ ✓ ✓
SDConfusional state · · ✓
SDCOVID-19 · · ✓
SDDyspnoea · · ✓
SDMastitis ✓ ✓ ✓
SDMenstrual clots · · ✓
SDMenstruation irregular · · ✓
SDPre-existing disease · · ✓
SDRash ✓ ✓ ✓
SDRash erythematous ✓ ✓ ✓
SDRash maculo-papular ✓ ✓ ✓
SDRash pruritic ✓ ✓ ✓
SROAsthenia ✓ ✓ ✓
SRODizziness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…